Agios PharmaceuticalsvsThermo Fisher Scientific

AGIO and TMO stock compared: price, dividend, valuation and results, from SEC filings.

AGIO

Agios Pharmaceuticals, Inc.

$30.15

Value $1.8B

-4.56%
AGIO's page

TMO

Thermo Fisher Scientific Inc

$691.33

Value $257B

-1.27%
TMO's page

Agios Pharmaceuticals (AGIO) has a market value of $1.8B and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, AGIO moved -30.9% and TMO +19.9%. Dividend yield: AGIO none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AGIO$1.8B

    TMO$257B

    TMO is 145 times AGIO

  • Revenue, 12 months

    AGIO$141M

    TMO$47.4B

    TMO is 336 times AGIO

  • Net income, 12 months

    AGIO-$373M

    TMO$7.1B

  • Operating margin

    AGIO-297.7%

    TMO17.9%

    315.6 points apart

  • ROIC

    AGIO-29.6%

    TMO8.2%

    37.8 points apart

  • P/E

    AGIO–

    TMO36.3

  • Dividend yield

    AGIO0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    AGIO-25.7%

    TMO+10.9%

    36.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AGIO-25.7%

TMO+10.9%

5010015020222023202420252026
Returns by period
PeriodAGIOWith dividendsTMOWith dividends
1 year since November 14, 2025-30.9%Price -30.9%+19.9%Price +19.5%
3 years since November 16, 2023+35.6%+10.7% a yearPrice +35.6%+47.7%+13.9% a yearPrice +46.3%
5 years since November 15, 2021-25.7%-5.8% a yearPrice -25.7%+10.9%+2.1% a yearPrice +9.3%
10 years since November 16, 2016-51.3%-6.9% a yearPrice -51.3%+375.7%+16.9% a yearPrice +362.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AGIOAgios PharmaceuticalsTMOThermo Fisher Scientific

Valuation

AGIOTMO
Valuation
Price$30.15$691.33
Market value$1.8B$257B
Enterprise value (EV)$860M$292B
P/E–36.3
P/E, 5-year median–32.7
P/B1.84.7
EV/EBIT–34.5
Free cash flow yield–3.0%

Results and growth

AGIOTMO
Results and growth
Revenue, 12 months$141M$47.4B
Net income, 12 months-$373M$7.1B
Free cash flow, 12 months-$336M$7.6B
Earnings per share, 12 months-$6.32$18.96
Revenue growth, year on year48.0%3.9%
Revenue growth a year, past–+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

AGIOTMO
Margins and returns on capital
Gross margin93.8%–
Operating margin-297.7%17.9%
Net margin-264.8%14.9%
ROIC-29.6%8.2%
ROE-33.3%13.4%

Balance sheet

AGIOTMO
Balance sheet
Cash$907M$6.1B
Total debt$27M$41.4B
Net debt / EBITDA–3.7
Interest cover–5.5×

Dividends and buybacks

AGIOTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AGIO or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Agios Pharmaceuticals or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 145.4 times Agios Pharmaceuticals ($1.8B), at today's prices.

How did AGIO and TMO stock do over the last 10 years?

Since November 16, 2016, AGIO's price moved -51.3% and TMO's +362.5%. With dividends: AGIO -51.3% (-6.9% a year), TMO +375.7% (+16.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, AGIO or TMO?

The dividend yield at today's price is none for Agios Pharmaceuticals and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Agios Pharmaceuticals or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -264.8% for Agios Pharmaceuticals and 14.9% for Thermo Fisher Scientific, and the operating margin -297.7% and 17.9%. Revenue was $141M and $47.4B.

Which is the better investment, Agios Pharmaceuticals or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.